• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒药物与角膜伤口愈合。

Antiviral medications and corneal wound healing.

作者信息

Lass J H, Langston R H, Foster C S, Pavan-Langston D

出版信息

Antiviral Res. 1984 Jun;4(3):143-57. doi: 10.1016/0166-3542(84)90014-7.

DOI:10.1016/0166-3542(84)90014-7
PMID:6476819
Abstract

Masked controlled rabbit studies were done to determine the toxic effects on corneal wound healing of the antiviral ointments 0.5% idoxuridine, 3% Ara A, and 3% acyclovir, and the antiviral drops 0.1% idoxuridine, 3% Ara AMP, and 1% trifluridine. Ara A, acyclovir, trifluridine and idoxuridine drops had no significant effects on the rate of closure of epithelial wounds. Idoxuridine ointment given 5 times a day significantly retarded the rate of epithelial wound closure, but not when given 4 times a day. Only Ara AMP caused a retardation of epithelial healing and an actual increase in the defect after 4 days of treatment. Histopathologically all drugs, except acyclovir, showed a toxic effect on the regenerating epithelium. All drugs, except acyclovir, showed retarded stromal wound healing with reduced bursting strength and collagen content. Ara AMP had increased bursting strength and collagen content possibly because of greater inflammation. Acyclovir, in comparison to all the other medications studied, appeared to have minimal to no toxic effects on experimental epithelial and stromal wound healing, and on this basis is the agent of choice for use in herpes simplex stromal keratitis with ulceration and as a prophylactic agent for long-term use after penetrating keratoplasty.

摘要

进行了遮蔽对照兔研究,以确定0.5%碘苷、3%阿糖腺苷和3%阿昔洛韦抗病毒软膏以及0.1%碘苷、3%阿糖腺苷单磷酸和1%三氟尿苷抗病毒滴眼液对角膜伤口愈合的毒性作用。阿糖腺苷、阿昔洛韦、三氟尿苷和碘苷滴眼液对上皮伤口的闭合速率没有显著影响。每天给药5次的碘苷软膏显著延缓上皮伤口的闭合速率,但每天给药4次时则无此现象。仅阿糖腺苷单磷酸在治疗4天后导致上皮愈合延迟且缺损实际增大。组织病理学上,除阿昔洛韦外,所有药物均对再生上皮显示出毒性作用。除阿昔洛韦外,所有药物均显示基质伤口愈合延迟,破裂强度和胶原蛋白含量降低。阿糖腺苷单磷酸的破裂强度和胶原蛋白含量增加,可能是由于炎症反应更强烈。与所研究的所有其他药物相比,阿昔洛韦对实验性上皮和基质伤口愈合似乎具有最小至无毒性作用,基于此,它是单纯疱疹性基质性角膜炎伴溃疡时的首选药物,也是穿透性角膜移植术后长期使用的预防药物。

相似文献

1
Antiviral medications and corneal wound healing.抗病毒药物与角膜伤口愈合。
Antiviral Res. 1984 Jun;4(3):143-57. doi: 10.1016/0166-3542(84)90014-7.
2
[Antiviral agents and corneal epithelium cicatrisation: study in rabbits (author's transl)].
J Fr Ophtalmol. 1981;4(12):797-804.
3
The treatment of herpes simplex virus epithelial keratitis.单纯疱疹病毒性上皮性角膜炎的治疗
Trans Am Ophthalmol Soc. 2000;98:505-32.
4
Corneal wound healing and antiviral medication.
Arch Ophthalmol. 1977 Nov;95(11):2062-7. doi: 10.1001/archopht.1977.04450110156022.
5
[Antiviral agents and cicatrization of the corneal stroma].
J Fr Ophtalmol. 1983;6(6-7):593-6.
6
Aciclovir and corneal wound healing.阿昔洛韦与角膜伤口愈合。
Am J Ophthalmol. 1979 Jul;88(1):102-8. doi: 10.1016/0002-9394(79)90762-1.
7
Antiviral drugs and corneal wound healing.
Invest Ophthalmol. 1975 Aug;14(8):628-30.
8
Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.西多福韦、曲氟尿苷和阿昔洛韦在单纯疱疹病毒1型兔角膜炎模型中的抗病毒疗效比较。
Invest Ophthalmol Vis Sci. 1999 Feb;40(2):378-84.
9
Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.阿昔洛韦耐药性疱疹性角膜炎的临床特征及分离株的实验研究
Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234 Suppl 1:S126-32. doi: 10.1007/BF02343061.
10
Topical nonsteroidal agents and corneal wound healing.局部用非甾体类药物与角膜伤口愈合。
Arch Ophthalmol. 1990 Apr;108(4):577-83. doi: 10.1001/archopht.1990.01070060125062.

引用本文的文献

1
Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.基于药物包裹碳(DECON)的持续药物释放平台的多种核苷类似物的安全性、疗效和传递。
Eur J Pharm Biopharm. 2022 Apr;173:150-159. doi: 10.1016/j.ejpb.2022.03.001. Epub 2022 Mar 21.
2
Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis.神经营养性角膜病变治疗效果的系统评价和荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2623-2637. doi: 10.1007/s00417-022-05602-z. Epub 2022 Mar 7.
3
Advancing Our Understanding of Corneal Herpes Simplex Virus-1 Immune Evasion Mechanisms and Future Therapeutics.
深入了解单纯疱疹病毒-1 角膜免疫逃逸机制和未来的治疗方法。
Viruses. 2021 Sep 17;13(9):1856. doi: 10.3390/v13091856.
4
Successful surgical and medical treatment of a severe, acute epidural bleed in a young dog due to steroid responsive meningitis-arteritis.由于类固醇反应性脑膜-动脉炎,一只年轻犬发生严重急性硬膜外血肿,经手术和内科治疗获得成功。
Acta Vet Scand. 2021 Jul 10;63(1):27. doi: 10.1186/s13028-021-00593-z.
5
Adoption of Innovation in Herpes Simplex Virus Keratitis.单纯疱疹病毒性角膜炎创新的采用。
Cornea. 2020 Nov;39 Suppl 1(1):S7-S18. doi: 10.1097/ICO.0000000000002425.
6
Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections.单纯疱疹病毒1型眼部感染的现有及新出现的治疗方法
Microorganisms. 2019 Oct 10;7(10):429. doi: 10.3390/microorganisms7100429.
7
An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye.BX795 的一种脱靶效应可阻断单纯疱疹病毒 1 型对眼部的感染。
Sci Transl Med. 2018 Feb 14;10(428). doi: 10.1126/scitranslmed.aan5861.
8
Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells.培养的角膜显示出树突状扩散,并限制单纯疱疹病毒感染,而在培养的角膜细胞中则观察不到这种现象。
Sci Rep. 2017 Feb 15;7:42559. doi: 10.1038/srep42559.
9
Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.从隐形眼镜中缓释抗硫酸乙酰肝素肽可抑制单纯疱疹病毒-1角膜感染。
Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):169-80. doi: 10.1167/iovs.15-18365.
10
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.单纯疱疹病毒性上皮性角膜炎的抗病毒治疗及其他治疗干预措施。
Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD002898. doi: 10.1002/14651858.CD002898.pub5.